Additionally, YY1 represses expression of death receptor 5 (DR5) and Fas, thereby conferring resistance to TRAIL and FasL induced apoptosis in prostate cancer cells [20–22]. The gene discussed is TNFRSF10B; the disease is prostate carcinoma.